Order Article Reprints

Vahidfar N, Farzanehfar S, Abbasi M, Mirzaei S, Delpassand ES, Abbaspour F, Salehi Y, Biersack HJ, Ahmadzadehfar H. Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [⁶⁴Cu]Cu-DOTA-TOC. Cancers. 2022; 14(8):1914. https://doi.org/10.3390/cancers14081914

Vahidfar, Nasim, Saeed Farzanehfar, Mehrshad Abbasi, Siroos Mirzaei, Ebrahim S. Delpassand, Farzad Abbaspour, Yalda Salehi, Hans Jürgen Biersack, and Hojjat Ahmadzadehfar. 2022. "Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [⁶⁴Cu]Cu-DOTA-TOC" Cancers 14, no. 8: 1914. https://doi.org/10.3390/cancers14081914

Vahidfar, N., Farzanehfar, S., Abbasi, M., Mirzaei, S., Delpassand, E. S., Abbaspour, F., Salehi, Y., Biersack, H. J., & Ahmadzadehfar, H. (2022). Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [⁶⁴Cu]Cu-DOTA-TOC. Cancers, 14(8), 1914. https://doi.org/10.3390/cancers14081914